ELAGOLIX | ELAGOLIX : Antagonist of GNRHR
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
GNRHR
  • Ki:0.9 nM
  • Kd:0.54 nM
  • IC50:1.5 nM
Antagonist
up to 100 nM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Elagolix was highly selective at hGnRH-R, its wider receptor selectivity was tested at a concentrati ...

Potency
Cellular
In Vitro

GNRHR

Mode of Action: Antagonist

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/jm8006454

In Vivo Validations

Rat
Dose: 10 mg/kg
Route of delivery: Intravenous, Oral
Plasma half life: 0.9 h
Systemic clearance: 33.3 mL/(min·kg)
Cmax: 338 ng/mL
Tmax: 0.25 h
Area Under the Curve:: 290 ng/(mL·h)
Bioavailability: 5.8%
Volume of Distribution at Steady-State: 2.6 L/Kg

DOI Reference: 10.1021/jm8006454

Mouse
Dose:
Route of delivery: Intravenous, Oral
Plasma half life: 0.3 h
Systemic clearance: 50 mL/(min·kg)
Cmax: 741 ng/mL
Tmax: 0.25 h
Area Under the Curve:: 326 ng/(mL·h)
Bioavailability: 10%
Volume of Distribution at Steady-State: 1.4 L/Kg

DOI Reference: 10.1021/jm8006454

Monkey (Rheus)
Dose:
Route of delivery: Intravenous, Oral
Plasma half life: 1.1 h
Systemic clearance: 25.7 mL/(min·kg)
Cmax: 518 ng/mL
Tmax: 0.69 h
Area Under the Curve:: 699 ng/(mL·h)
Bioavailability: 11%
Volume of Distribution at Steady-State: 2.5 L/Kg

DOI Reference: 10.1021/jm8006454

Dog
Dose: 50 mg/Kg PO
Route of delivery: Intravenous, Oral
Plasma half life: 2.8 h
Systemic clearance: 14.5 mL/(min·kg)
Cmax: 13900 ng/mL
Tmax: 2 h
Area Under the Curve:: 80700 ng/(mL·h)
Bioavailability: ∼100%
Volume of Distribution at Steady-State: 0.92 L/Kg

DOI Reference: 10.1021/jm8006454

Chemical Information

Molecular Formula C32H30F5N3O5
InChI InChI=1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1
Molecular weight 631.21 Da
AlogP 0.0
HBond acceptors 8
HBond donors 2
Atoms 75

References

Publications

Cross References

canSARChEMBLBindingDBPDB

Expert Reviews


(on 16 May 2025 )
Cellular Use Rating
In Model Organisms
Elagolix is a clinically validated GnRHR antagonist with strong utility as a chemical probe in systems where human GnRH receptor is expressed and functionally relevant. Elagolix is a highly effective...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria